angiotensin ii has been researched along with Death, Sudden, Cardiac in 11 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (9.09) | 18.2507 |
| 2000's | 6 (54.55) | 29.6817 |
| 2010's | 3 (27.27) | 24.3611 |
| 2020's | 1 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Abdelhamid, M; Adamopoulos, S; Anker, SD; Bayes-Genis, A; Ben Gal, T; Böhm, M; Chioncel, O; Coats, AJS; Filippatos, G; Jankowska, EA; Lopatin, Y; Lund, L; Metra, M; Milicic, D; Moura, B; Mullens, W; Piepoli, M; Rakisheva, A; Ristic, A; Rosano, G; Savarese, G; Seferovic, P; Thum, T | 1 |
| Abbott, GW; Anand, M; Christini, DJ; Hu, Z; Kant, R; King, EC; Krogh-Madsen, T | 1 |
| Bernstein, KE; Bonini, MG; Dolmatova, E; Dudley, SC; Duffy, HS; Iravanian, S; Jiao, Z; Kumar, V; Liu, H; Sovari, AA; Wang, K; Zandieh, S | 1 |
| Ai, T; Chen, PS | 1 |
| Ikeda, K; Leinwand, LA; Maass, AH; Maier, SK; Oberdorf-Maass, S | 1 |
| Rubart, M; Zipes, DP | 1 |
| Devereux, RB; Krauser, DG | 1 |
| Dechend, R; Dietz, R; Fiebeler, A; Fischer, R; Gapelyuk, A; Gratze, P; Gruner, A; Gruner, K; Luft, FC; Muller, DN; Qadri, F; Schirdewan, A; Shagdarsuren, E; Wellner, M | 1 |
| Karagueuzian, HS; Morita, N; Sovari, AA; Weiss, JN | 1 |
| Dietz, R; Gross, M; Gulba, D; Krämer, J; Osterziel, KJ; von Harsdorf, R; Willenbrock, R | 1 |
| Andreuzzi, B; Gronda, E; Mangiavacchi, M; Municinò, A | 1 |
5 review(s) available for angiotensin ii and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Prevention of sudden death in heart failure with reduced ejection fraction: do we still need an implantable cardioverter-defibrillator for primary prevention?
Topics: Adrenergic beta-Antagonists; Aldosterone; Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Death, Sudden, Cardiac; Defibrillators, Implantable; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Neprilysin; Norepinephrine; Primary Prevention; Receptors, Angiotensin; Sodium-Glucose Transporter 2 Inhibitors; Stroke Volume; Ventricular Function, Left | 2022 |
Neural modulation of cardiac arrhythmias and sudden cardiac death.
Topics: Angiotensin II; Animals; Arrhythmias, Cardiac; Autonomic Nervous System; Calcium Signaling; Death, Sudden, Cardiac; Heart; Humans; Nerve Regeneration; Renin-Angiotensin System | 2006 |
Ventricular hypertrophy and hypertension: prognostic elements and implications for management.
Topics: Adrenergic Antagonists; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Benzimidazoles; Benzoates; Carbazoles; Carvedilol; Chi-Square Distribution; Cohort Studies; Coronary Disease; Death, Sudden, Cardiac; Diuretics; Drug Therapy, Combination; Echocardiography; Electroencephalography; Enalapril; Female; Follow-Up Studies; Heart Failure; Humans; Hypertension; Hypertrophy, Left Ventricular; Indapamide; Logistic Models; Losartan; Male; Multivariate Analysis; Prognosis; Propanolamines; Prospective Studies; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Risk Factors; Sex Factors; Stroke; Survival Analysis; Telmisartan | 2006 |
Angiotensin II and coronary artery disease, congestive heart failure, and sudden cardiac death.
Topics: Angiotensin II; Coronary Disease; Death, Sudden, Cardiac; Heart Failure; Humans; Models, Cardiovascular | 1998 |
[Arrhythmia risk stratification in patients with heart failure according to drug treatment and its effects].
Topics: Adrenergic beta-Antagonists; Amiodarone; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Cardiotonic Agents; Death, Sudden, Cardiac; Diuretics; Heart Failure; Humans; Mineralocorticoid Receptor Antagonists; Myocardial Infarction; Pacemaker, Artificial; Prognosis; Randomized Controlled Trials as Topic; Risk; Risk Assessment; Spironolactone; Vasodilator Agents | 2001 |
6 other study(ies) available for angiotensin ii and Death, Sudden, Cardiac
| Article | Year |
|---|---|
Kcne2 deletion creates a multisystem syndrome predisposing to sudden cardiac death.
Topics: Anemia; Angiotensin II; Angiotensinogen; Animals; Arrhythmias, Cardiac; Death, Sudden, Cardiac; Diabetes Mellitus; Dyslipidemias; Gene Regulatory Networks; Genotype; Heterozygote; Hyperkalemia; Ischemia; Long QT Syndrome; Mice; Mice, Knockout; Potassium Channels, Voltage-Gated | 2014 |
Inhibition of c-Src tyrosine kinase prevents angiotensin II-mediated connexin-43 remodeling and sudden cardiac death.
Topics: Angiotensin II; Animals; Blotting, Western; Connexin 43; CSK Tyrosine-Protein Kinase; Death, Sudden, Cardiac; Disease Models, Animal; Enzyme Inhibitors; Gap Junctions; Immunohistochemistry; Mice; Mice, Transgenic; Phosphorylation; Protein-Tyrosine Kinases; Pyrazoles; Pyrimidines; src-Family Kinases; Tachycardia, Ventricular; Telemetry; Ventricular Fibrillation | 2011 |
Is c-Src tyrosine kinase a new target for antiarrhythmic drug therapy?
Topics: Angiotensin II; Animals; Connexin 43; CSK Tyrosine-Protein Kinase; Death, Sudden, Cardiac; Gap Junctions; Protein-Tyrosine Kinases; src-Family Kinases | 2011 |
Hypertrophy, fibrosis, and sudden cardiac death in response to pathological stimuli in mice with mutations in cardiac troponin T.
Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Amino Acid Substitution; Angiotensin II; Animals; Body Weight; Cardiomyopathy, Hypertrophic, Familial; Cell Size; Death, Sudden, Cardiac; Female; Fibrosis; Gene Expression Profiling; Isoproterenol; Male; Mice; Mice, Inbred C57BL; Mice, Transgenic; Mutation; Mutation, Missense; Myocytes, Cardiac; Organ Size; Phenotype; Phenylephrine; Point Mutation; Protein Isoforms; RNA Splice Sites; RNA, Messenger; Sex Characteristics; Troponin T | 2004 |
Angiotensin II-induced sudden arrhythmic death and electrical remodeling.
Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiac Pacing, Artificial; Cardiomegaly; Connexin 43; Death, Sudden, Cardiac; Disease Models, Animal; Electrocardiography; Heart Conduction System; Hypertension; Losartan; Male; Myocardium; Rats; Rats, Sprague-Dawley; Renin; RNA, Messenger; Shal Potassium Channels; Tachycardia, Ventricular; Telemetry; Time Factors; Ventricular Remodeling | 2007 |
Serum transforming growth factor-beta1 as a risk stratifier of sudden cardiac death.
Topics: Angiotensin II; Cost-Benefit Analysis; Death, Sudden, Cardiac; Fibrosis; Humans; Ions; Models, Biological; Models, Theoretical; Myocardium; Risk; Tachycardia, Ventricular; Transforming Growth Factor beta1; Ventricular Fibrillation | 2008 |